Correction to “A Pt(IV) Pro-Drug Preferentially Targets Indoleamine-2,3-Dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy”
Journal of the American Chemical Society - United States
doi 10.1021/jacs.6b01316
Full Text
Open PDFAbstract
Available in full text
Date
February 26, 2016
Authors
Publisher
American Chemical Society (ACS)